A biotechnology firm is growing at a compound rate of more than 21 percent a year. (Its ROE is over 30 percent, and it retains about 70 percent of its earnings.) The stock of this company is priced at about 65 times next year's earnings. Discuss whether you consider this a growth company and/or a growth stock.
Answer to relevant QuestionsUnder what conditions would you use a two-or three-stage cash flow model rather than the constant-growth model?Specify the major components for the calculation of economic value added. Describe what a positive EVA signifies.Discuss the major assumptions of the growth duration model. Why could these assumptions present a problem?Lauren Entertainment, Inc., has an 18 percent annual growth rate compared to the market rate of 8 percent. If the market multiple is 18, determine P/E ratios for Lauren Entertainment, Inc., assuming its beta is 1.0 and you ...Briefly discuss the problems related to fundamental analysis that are considered advantages for technical analysis.
Post your question